Effect of short-term electrical stimulation before and after botulinum toxin injection

Journal of Rehabilitation Medicine

Volumn 43, Issue 5, 2011, Pages 420-423

  Santus, Gianna ^a   Faletti, Sofia ^a   Bordanzi, Ingrid ^a   Pirali, Francesco ^b   De Grandis, Domenico ^a  

^a S Orsola Hospital   (Italy)

^b CREMONA HOSPITAL   (Italy)

Author keywords

Botulinum toxin type A; Electrical nerve stimulation; Neurophysiology; Spasticity

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ACTION POTENTIAL; ADULT; ARTICLE; DRUG EFFECT; ELECTROSTIMULATION THERAPY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MIDDLE AGED; PHYSIOLOGY; SKELETAL MUSCLE; SPASTICITY;

ACTION POTENTIALS; ADULT; BOTULINUM TOXINS, TYPE A; ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; MUSCLE SPASTICITY; MUSCLE, SKELETAL; NEUROMUSCULAR AGENTS;

EID: 79955930766     PISSN: 16501977     EISSN: None     Source Type: Journal    
DOI: 10.2340/16501977-0790     Document Type: Article

References (29)

1. Wissel J, Ward AB, Erztgaard P, Bensmail D, Hecht MJ, Lejeune TM, et al. European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med 2009; 41: 13-25.
2. Montecucco C, Molgo J. Botulinum neurotoxin: revival of an old killer. Curr Opin Pharmacol 2005; 5: 274-279. (Pubitemid 40674251)
3. Rossetto O, Seveso M, Caccin P, Schiavo G, Montecucco C. Tetanus and botulinum neurotoxins: turning bad guys into good by research. Toxicon 2001; 39: 27-41. (Pubitemid 30628927)
4. Tugnoli V, Eleopra R, Montecucco C, De Grandis D. The therapeutic use of botulinum toxin. Expert Opin Investig Drugs 1997; 6: 1383-1394. (Pubitemid 27432480)
5. Baricich A, Carda S, Bertoni M, Maderna L, Cisari C. A singleblinded, randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot. J Rehabil Med 2008; 40: 870-872.
6. Hesse S, Reiter F, Konrad M, Jahnke MT. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial. Clin Rehabil 1998; 12: 381-388. (Pubitemid 28464099)
7. Verderio C, Rossetto O, Grumelli C, Frassoni C, Montecucco C, Matteoli M. Entering neurons: botulinum toxins and synaptic vesicle recycling. EMBO Reports 2006; 7: 995-999. (Pubitemid 44480513)
8. Kiaerulff O, Verstreken P, Bellen HJ. Synaptic vesicle retrieval: still time for a kiss. Nature Cell Biol 2002; 4: E245-E248. (Pubitemid 35331348)
9. Wu X, Wu L. Rapid endocytosis does not recycle vesicles within the readily releasable pool. J Neurosci 2009; 29: 11038-11042.
10. Schweizer F, Ryan T. The synaptic vesicle: cycle of exocytosis and endocytosis. Curr Opin Neurobiol 2006; 16: 298-304. (Pubitemid 44192495)
11. Cheng LW, Stanker LH, Henderson TD, Lou J, Marks JD. Antibody protection against botulinum neurotoxin intoxication in mice. Infect Immun 2009; 77: 4305-4313.
12. Granseth B, Odermatt B, Rojle S, Lagnado L. Clathrin-mediated endocytosis: the physiological mechanism of vesicle retrieval at hippocampal synapses. J Physiol 2007; 585: 681-686. (Pubitemid 350278705)
13. Zhu Y, Xu J, Heinemann SF. Two pathways of synaptic vesicle retrieval revealed by single vesicle imaging. Neuron 2009; 61: 397-411.
14. Bayram S, Sivrioglu K, Karli N, Ozcan O. Low-dose botulinum toxin with short term electrical stimulation in poststroke spastic drop foot. Am J Phys Med Rehabil 2006; 85: 75-81. (Pubitemid 43004858)
15. Grumelli C, Verderio C, Pozzi D, Rossetto O, Montecucco C, Matteoli M. Internalization and mechanism of action of clostridial toxins in neurons. Neurotoxicology 2005; 26: 761-767. (Pubitemid 41427515)
16. Ravichandran E, Gong Y, Al Saleem FH, Ancharski DM, Joshi SG, Simpson LL. An initial assessment of the systemic pharmacokinetics of botulinum toxin. J Pharmacol Exper Ther 2006; 318: 1343-1351. (Pubitemid 44268344)
17. Montecucco C, Rossetto O, Schiavo G. Presynaptic receptor arrays for clostridial neurotoxins. Trends Microbiol 2004; 12: 442-446. (Pubitemid 39286121)
18. Eleopra R, Tugnoli V, De Grandis D. The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans. Mov Disord 1997; 12: 89-94. (Pubitemid 27032885)
19. Frasson E, Priori A, Ruzzante B, Didonè G, Bertolasi L. Nerve stimulation boots botulinum toxin action in spasticity. Mov Disorder 2005; 20: 624-629. (Pubitemid 40862264)
20. Esquenazi A, Mayer N. Electric stimulation to prolong the duration of botulinum toxin type A effect on spasticity: a double-blind, placebo-controlled study. Arch Phys Med Rehabil 2007; 88: E105.
21. Simpson LL. Kinetic studies on the interaction between botulinum toxin type A and cholinergic neuromuscolar junction. J Pharmacol Exp Ther 1980; 212: 16-21. (Pubitemid 10131942)
22. Gordon PH., Gooch CL, Greene PE. Extensor digitorum brevis test and resistance to botulinum toxin type A. Muscle Nerve 2002; 26: 828-831. (Pubitemid 35424435)
23. Hamjian JA, Walker FO. Serial neurophysiological studies of intramuscolar botulinum toxin-A in humans. Muscle Nerve 1994; 17: 1385-1392. (Pubitemid 24362810)
24. Torii Y, Goto Y, Takahashi M, Ishida S, Harakawa T, Sakamoto T, et al. Quantitative determination of biological activity of botulinum toxins utilizing compound muscle action potentials (CMAP), and comparison of neuromuscolar transmission blockage and muscle flaccidity among toxins. Toxicon 2010; 55: 407-414.
25. Sloop RR, Escutin RO, Matus JA, Cole BA, Peterson GW. Doseresponse curve of human extensor digitorum brevis muscle function to intramuscularly injected botulinum toxin type A. Neurology 1996; 46: 1382-1386. (Pubitemid 26164651)
26. Seib TP, Price R, Reyer MR, Lehmann JF. The quantitative measurement of spasticity: effect of cutaneous electrical stimulation. Arch Phys Med Rehabil 1994; 75: 746-750. (Pubitemid 24222068)
27. Detrembleur C, Lejeune TM, Renders A, Van Den Bergh PY. Botulinum toxin and short-term electrical stimulation in the treatment of equinus in cerebral palsy. Mov Desord 2002; 17: 162-169. (Pubitemid 36054149)
28. Kang BS, Bang MS, Jung SH. Effects of botulinum toxin A therapy with electrical stimulation on spastic calf muscles in children with cerebral palsy. Am J Phys Med Rehabil 2007; 86: 901-906. (Pubitemid 351339387)
29. Rha DW, Yang EJ, Chung HI, Kim HB, Park C, Park ES. Is electrical stimulation beneficial for improving the paralytic effect of botulinum toxin type A in children with spastic diplegic cerebral palsy? Yonsei Med J 2008; 49: 545-552.